Amuvatinib

Generic Name
Amuvatinib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C23H21N5O3S
CAS Number
850879-09-3
Unique Ingredient Identifier
SO9S6QZB4R
Background

Amuvatinib has been used in trials studying the treatment of Solid Tumors and Small Cell Lung Carcinoma. Amuvatinib is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer ce...

Indication

Amuvatinib is a selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer cells.

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath